GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » Earnings per Share (Diluted)

Centene (Centene) Earnings per Share (Diluted) : $4.91 (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Centene Earnings per Share (Diluted)?

Centene's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.08. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $4.91.

Centene's EPS (Basic) for the three months ended in Dec. 2023 was $0.08. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $4.93.

Centene's EPS without NRI for the three months ended in Dec. 2023 was $0.45. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $6.66.

During the past 12 months, Centene's average EPS without NRIGrowth Rate was 15.60% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 10.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 25.60% per year.

During the past 13 years, Centene's highest 3-Year average EPS without NRI Growth Rate was 58.50% per year. The lowest was -14.90% per year. And the median was 18.50% per year.


Centene Earnings per Share (Diluted) Historical Data

The historical data trend for Centene's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Earnings per Share (Diluted) Chart

Centene Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.14 3.12 2.28 2.07 4.95

Centene Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 2.04 1.92 0.87 0.08

Competitive Comparison of Centene's Earnings per Share (Diluted)

For the Healthcare Plans subindustry, Centene's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Centene's PE Ratio Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Centene's PE Ratio distribution charts can be found below:

* The bar in red indicates where Centene's PE Ratio falls into.



Centene Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Centene's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2702-0)/545.704
=4.95

Centene's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(45-0)/537.580
=0.08

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Centene  (NYSE:CNC) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Centene Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Centene's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Centene (Centene) Business Description

Industry
Address
7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
Executives
Lori Jean Robinson director 5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher officer: EVP, CFO 8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray officer: EVP, Chief Transform. Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii director 1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford director C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola officer: EVP, Health Care Enterprises 500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley officer: EVP, Chief Admin. Officer 7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt director 822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin director
H James Dallas director 127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks officer: SVP, Chief Information Officer 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas officer: EVP, MARKETS 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A officer: EVP, Mergers & Acquisitions 7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105

Centene (Centene) Headlines